Methyl 3-Hydroxy-2-thiophenecarboxylate>97.0%(GC)1g

4-(Ethoxymethyl)piperidin-4-ol hydrochloride, 98%, 10g

(2,2-Dimethyl-2,3-dihydrobenzofuran-5-yl)boronic acid, 95%, 2.5g

7-Aminonaphthalene-1,3,6-trisulfonic acid, 95.0%, 10g

MOCLOBEMIDE, 95%, 250mg

5-(2-methylphenyl)-1H-pyrazole, 95.0%, 5g

tert-Butyl 6-(2-ethoxy-2-oxoethyl)-2-azaspiro[3.3]heptane-2-carboxylate, 97%, 100mg

2-Iodo-1,4-benzenediamine, 95.0%, 10g

4,5-Dichlorophthalic acid, 95.0%, 10g

4-(4-Chlorobenzyl)-piperidine hydrochloride, 95.0%, 250mg

4,6-Dimethylpyrimidin-2-ol hydrochloride, 95.0%, 25g

Obiettivo per contrasto di fase Plan PLPH S40x/0,65

3-chloro-5-methoxy-1-methyl-1H-1,2,4-triazole, 95.0%, 1g